Orchid Gets USFDA Nod for Cephalexin
Orchid Chemicals & Pharmaceuticals Ltd today said it has received approval from the USFDA for its ANDA (Abbreviated New Drug Application) of Cephalexin oral suspension. // ....Cephalexin, an off-patent molecule, forms part of Orchid Chemicals' distribution alliance with US generic pharma major Par Pharmaceuticals Inc, it informed the Bombay Stock Exchange... ..Orchid added that its Cephalexin ca...Orchid to Buy out Bexel Pharma, US
Looking to consolidate its research activities under a common umbrella, Orchid Chemicals & Pharmaceuticals Ltd today said it will buyout US-based Bexel Pharmaceuticals Inc by acquiring a 26 per cent stake // , for over Rs 13 crore (three million dollars). ....The company holds a majority 74 per cent stake in Bexel Pharma and would acquire the remaining 26 per cent stake as a part of an agreement...Orchid Chemicals & Pharmaceuticals, a leading player in the Indian drug industry, has received a formal approval from the US Food and Drug Authority (FDA) for three// of its abbreviated new drug applications (ANDAs) for Cefotaxime. ....Orchid will be launching this product in the US through its exclusive distribution partner, Apotex, the Chennai-based company said in a release Wednesday. ....T...Chennai:- Pharma major Orchid Chemicals and Pharmaceuticals Ltd has getting approval from US Food and Drug Administration (FDA) for its abbreviated new anti-biotic drug application for Cefepime injection. ......Cefepime injection is a life saving cephalosporin antibiotic drug with an annual sale of $190 million, and is used in hospital settings. ......"Orchid's Cefepime approval for the US gen...